Literature DB >> 19151038

In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).

Aleksandra K Wierzbowski, James A Karlowsky, Daryl J Hoban, George G Zhanel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19151038     DOI： 10.1093/jac/dkn532

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  CEM-101 activity against Gram-positive organisms.

Authors:  Leah N Woosley; Mariana Castanheira; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  MIC quality control guidelines and disk diffusion test optimization for CEM-101, a novel fluoroketolide.

Authors:  Ronald N Jones; James E Ross; Paul R Rhomberg
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

3.  A novel ketolide, RBx 14255, with activity against multidrug-resistant Streptococcus pneumoniae.

Authors:  V Samuel Raj; Tarani Kanta Barman; Vandana Kalia; Kedar Purnapatre; Smita Dube; Ramkumar G; Pragya Bhateja; Tarun Mathur; Tridib Chaira; Dilip J Upadhyay; Yogesh B Surase; R Venkataramanan; Anjan Chakrabarti; Biswajit Das; Pradip K Bhatnagar
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.